273 related articles for article (PubMed ID: 31829901)
1. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
Schneider BJ; Ismaila N; Aerts J; Chiles C; Daly ME; Detterbeck FC; Hearn JWD; Katz SI; Leighl NB; Levy B; Meyers B; Murgu S; Nekhlyudov L; Santos ES; Singh N; Tashbar J; Yankelevitz D; Altorki N
J Clin Oncol; 2020 Mar; 38(7):753-766. PubMed ID: 31829901
[TBL] [Abstract][Full Text] [Related]
2. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Daly ME; Singh N; Ismaila N; Antonoff MB; Arenberg DA; Bradley J; David E; Detterbeck F; Früh M; Gubens MA; Moore AC; Padda SK; Patel JD; Phillips T; Qin A; Robinson C; Simone CB
J Clin Oncol; 2022 Apr; 40(12):1356-1384. PubMed ID: 34936470
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
[TBL] [Abstract][Full Text] [Related]
4. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Colt HG; Murgu SD; Korst RJ; Slatore CG; Unger M; Quadrelli S
Chest; 2013 May; 143(5 Suppl):e437S-e454S. PubMed ID: 23649451
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.
Ho QA; Harandi NK; Daly ME
Clin Lung Cancer; 2017 Jul; 18(4):410-414. PubMed ID: 28007410
[TBL] [Abstract][Full Text] [Related]
6. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Khurshid H; Ismaila N; Bian J; Dabney R; Das M; Ellis P; Feldman J; Hann C; Kulkarni S; Laskin J; Manochakian R; Mishra DR; Preeshagul I; Reddy P; Saxena A; Weinberg F; Kalemkerian GP
J Clin Oncol; 2023 Dec; 41(35):5448-5472. PubMed ID: 37820295
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
8. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.
Yilmaz E; Ismaila N; Bauman JE; Dabney R; Gan G; Jordan R; Kaufman M; Kirtane K; McBride SM; Old MO; Rooper L; Saba NF; Sheth S; Subramaniam RM; Wise-Draper TM; Wong D; Mell LK
J Clin Oncol; 2023 Feb; 41(5):1132-1146. PubMed ID: 36521102
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
Kris MG; Gaspar LE; Chaft JE; Kennedy EB; Azzoli CG; Ellis PM; Lin SH; Pass HI; Seth R; Shepherd FA; Spigel DR; Strawn JR; Ung YC; Weyant M
J Clin Oncol; 2017 Sep; 35(25):2960-2974. PubMed ID: 28437162
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.
Chen YP; Ismaila N; Chua MLK; Colevas AD; Haddad R; Huang SH; Wee JTS; Whitley AC; Yi JL; Yom SS; Chan ATC; Hu CS; Lang JY; Le QT; Lee AWM; Lee N; Lin JC; Ma B; Morgan TJ; Shah J; Sun Y; Ma J
J Clin Oncol; 2021 Mar; 39(7):840-859. PubMed ID: 33405943
[TBL] [Abstract][Full Text] [Related]
12. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.
Koyfman SA; Ismaila N; Crook D; D'Cruz A; Rodriguez CP; Sher DJ; Silbermins D; Sturgis EM; Tsue TT; Weiss J; Yom SS; Holsinger FC
J Clin Oncol; 2019 Jul; 37(20):1753-1774. PubMed ID: 30811281
[TBL] [Abstract][Full Text] [Related]
13. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
14. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline.
Mikhael J; Ismaila N; Cheung MC; Costello C; Dhodapkar MV; Kumar S; Lacy M; Lipe B; Little RF; Nikonova A; Omel J; Peswani N; Prica A; Raje N; Seth R; Vesole DH; Walker I; Whitley A; Wildes TM; Wong SW; Martin T
J Clin Oncol; 2019 May; 37(14):1228-1263. PubMed ID: 30932732
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM
J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
[TBL] [Abstract][Full Text] [Related]
18. Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis.
Stirling RG; Chau C; Shareh A; Zalcberg J; Fischer BM
J Thorac Oncol; 2021 May; 16(5):784-797. PubMed ID: 33588110
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation.
Bodor JN; Feliciano JL; Edelman MJ
Lung Cancer; 2019 Sep; 135():16-20. PubMed ID: 31446989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
